Vendor Neutral Archive (VNA) & PACS Market worth US$7.92 billion by 2030 with 9.2% CAGR | MarketsandMarkets

DELRAY BEACH, Fla., May 15, 2025 /PRNewswire/ -- The global Vendor Neutral Archive (VNA) & PACS Market, valued at US$4.62 billion in 2024, is forecasted to grow at a robust CAGR of 9.2%, reaching US$5.10 billion in 2025 and an impressive US$7.92 billion by 2030. The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, AI, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1255

Browse in-depth TOC on "Vendor Neutral Archive (VNA) & PACS Market"

310 - Tables

47 - Figures

350 - Pages

By Based on product type, the VNA & PACS market is categorized into VNA and PACS. In 2024, the VNA segment accounted for a larger market share due to its ability to decouple medical imaging data from proprietary departmental systems. This methodology facilitates centralized data storage, improves interoperability, and significantly lowers operational, support, and data migration expenditures. VNAs play a crucial role in ensuring compliance with regulatory frameworks such as the HIPAA Security Rule by offering standardized and secure access to imaging data. Additionally, the increasing shift towards cloud-based VNA solutions is driving segment expansion, as these platforms provide seamless remote access for telemedicine applications, facilitate multidisciplinary collaboration, and support off-site diagnostics—capabilities that are essential in a progressively interconnected and decentralized healthcare environment.

By modality, the VNA & PACS market is segmented into CT, mammography, MRI, ultrasound, X-ray, and PET. Among these, the PET segment is expected to register the fastest CAGR during the forecast period. The expansion of PET imaging utilization across oncology, neurology, and cardiology is largely attributed to its capacity to deliver nuanced metabolic and physiological insights. The increasing necessity for early and precise disease detection, coupled with advancements in hybrid imaging technologies such as PET/CT and PET/MRI, propels its adoption. Furthermore, the integration of PET imaging within enterprise imaging frameworks and vendor-neutral archives enhances data management efficiencies and promotes its uptake among healthcare systems that prioritize precision medicine and value-based care strategies.